John Aballi
Chief Executive Officer chez EXAGEN INC.
Fortune : 955 253 $ au 31/03/2024
Profil
John Aballi is currently the President, Chief Executive Officer & Director at Exagen, Inc. He previously held positions as the Director at PFS Genomics, Inc., Head-Laboratory & Cartesian Operations at Genoptix, Inc., SVP, General Manager, COO-Urology & CLIA at Veracyte, Inc., Chief Operating Officer at Veracyte SD, Inc., and Head-Operations at Molecular Stethoscope, Inc. Mr. Aballi obtained an MBA from California Baptist University and an undergraduate degree from the University of California San Diego.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
EXAGEN, INC.
3,49% | 29/02/2024 | 600 788 ( 3,49% ) | 955 253 $ | 31/03/2024 |
Postes actifs de John Aballi
Sociétés | Poste | Début |
---|---|---|
EXAGEN INC. | Chief Executive Officer | 17/10/2022 |
Anciens postes connus de John Aballi
Sociétés | Poste | Fin |
---|---|---|
Veracyte SD, Inc.
Veracyte SD, Inc. Miscellaneous Commercial ServicesCommercial Services Decipher Biosciences, Inc. is a commercial-stage precision oncology company which engages in patient care improvement. The Company?s differentiated approach measures the biological activity of a patient?s entire tumor genome, known as whole transcriptome analysis, and applies proprietary machine learning algorithms to improve therapy selection and accelerate adoption of new therapies into the standard of care. Its novel prostate cancer genomic testing products examine the underlying biology of a patient?s tumor, enabling physicians to select an optimal therapy. The firm?s whole transcriptome analysis of clinical patient samples from its commercial channel and its participation in practice-changing clinical trials has allowed it to build and expand its Decipher GRID database GRID. The company was founded by Elai Davicioni, Timothy J. Triche, Bruce A. Schmidt, and Jonathan D. Buckley and is headquartered in San Diego, CA. | Chief Operating Officer | 01/03/2021 |
PFS Genomics, Inc.
PFS Genomics, Inc. Hospital/Nursing ManagementHealth Services PFS Genomics, Inc. provides radiation therapy for breast cancer treatment. The company was founded by Lori J. Pierce, Felix Y. Feng and Corey W. Speers and is headquartered in Vancouver, Canada. | Director/Board Member | 01/01/2021 |
Molecular Stethoscope, Inc.
Molecular Stethoscope, Inc. Medical/Nursing ServicesHealth Services Molecular Stethoscope, Inc. provides molecular diagnostics services. It offers novel blood-based early detection and disease monitoring tests to detect liver, coronary artery, inflammatory, neurodegenerative, coronary artery, autoimmune and inflammatory diseases. The company was founded by Stephen D. Phil Quake and Eric J. Topol on September 1, 2015 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/08/2018 |
Genoptix, Inc.
Genoptix, Inc. Medical SpecialtiesHealth Technology Genoptix, Inc. provides specialized oncology diagnostics services. It offers a range of customizable clinical trial, custom assay development and companion diagnostics development services. The company was founded in 1999 by Tina S. Nova and is headquartered in Carlsbad, CA. | Corporate Officer/Principal | 01/09/2015 |
VERACYTE, INC. | Corporate Officer/Principal | - |
Formation de John Aballi
California Baptist University | Masters Business Admin |
University of California San Diego | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
VERACYTE, INC. | Health Technology |
EXAGEN INC. | Health Services |
Entreprise privées | 4 |
---|---|
Genoptix, Inc.
Genoptix, Inc. Medical SpecialtiesHealth Technology Genoptix, Inc. provides specialized oncology diagnostics services. It offers a range of customizable clinical trial, custom assay development and companion diagnostics development services. The company was founded in 1999 by Tina S. Nova and is headquartered in Carlsbad, CA. | Health Technology |
Veracyte SD, Inc.
Veracyte SD, Inc. Miscellaneous Commercial ServicesCommercial Services Decipher Biosciences, Inc. is a commercial-stage precision oncology company which engages in patient care improvement. The Company?s differentiated approach measures the biological activity of a patient?s entire tumor genome, known as whole transcriptome analysis, and applies proprietary machine learning algorithms to improve therapy selection and accelerate adoption of new therapies into the standard of care. Its novel prostate cancer genomic testing products examine the underlying biology of a patient?s tumor, enabling physicians to select an optimal therapy. The firm?s whole transcriptome analysis of clinical patient samples from its commercial channel and its participation in practice-changing clinical trials has allowed it to build and expand its Decipher GRID database GRID. The company was founded by Elai Davicioni, Timothy J. Triche, Bruce A. Schmidt, and Jonathan D. Buckley and is headquartered in San Diego, CA. | Commercial Services |
Molecular Stethoscope, Inc.
Molecular Stethoscope, Inc. Medical/Nursing ServicesHealth Services Molecular Stethoscope, Inc. provides molecular diagnostics services. It offers novel blood-based early detection and disease monitoring tests to detect liver, coronary artery, inflammatory, neurodegenerative, coronary artery, autoimmune and inflammatory diseases. The company was founded by Stephen D. Phil Quake and Eric J. Topol on September 1, 2015 and is headquartered in San Diego, CA. | Health Services |
PFS Genomics, Inc.
PFS Genomics, Inc. Hospital/Nursing ManagementHealth Services PFS Genomics, Inc. provides radiation therapy for breast cancer treatment. The company was founded by Lori J. Pierce, Felix Y. Feng and Corey W. Speers and is headquartered in Vancouver, Canada. | Health Services |